{
    "root": "6ec783d3-9308-4f6b-bfda-b41888b95102",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Clarinex",
    "value": "20250517",
    "ingredients": [
        {
            "name": "DESLORATADINE",
            "code": "FVF865388R"
        },
        {
            "name": "DIBASIC CALCIUM PHOSPHATE DIHYDRATE",
            "code": "O7TSZ97GEP"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "CARNAUBA WAX",
            "code": "R12CBM0EIZ"
        },
        {
            "name": "WHITE WAX",
            "code": "7G1J5DA97F"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "FD&C Blue No. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "ALUMINUM OXIDE",
            "code": "LMI26O6933"
        }
    ],
    "indications": "clarinex histamine-1 ( h1 ) receptor antagonist indicated : seasonal allergic rhinitis : relief nasal non-nasal symptoms patients 2 years age older . ( 1.1 ) perennial allergic rhinitis : relief nasal non-nasal symptoms patients 6 months age older . ( 1.2 ) chronic idiopathic urticaria : symptomatic relief pruritus , reduction number hives , size hives patients 6 months age older . ( 1.3 )",
    "contraindications": "although oral solution orally disintegrating tablet formulation desloratadine may available marketplace , clarinex® oral solution clarinex® reditabs® tablets longer marketed . clarinex tablets , oral solution , reditabs tablets may taken without regard meals . place clarinex ( desloratadine ) reditabs tablets tongue allow disintegrate swallowing . tablet disintegration occurs rapidly . administer without water . take tablet immediately opening blister . age-appropriate dose clarinex oral solution administered commercially available measuring dropper syringe calibrated deliver 2 ml 2.5 ml ( ½ teaspoon ) .",
    "warningsAndPrecautions": "clarinex tablets : embossed “ c5 ” , light blue , film-coated tablets packaged high-density polyethylene plastic bottles 100 ( ndc 78206-119-01 ) . embossed elongated letters “ ” “ p ” , light blue , film-coated tablets packaged high-density polyethylene plastic bottles 100 ( ndc 78206-188-01 ) .",
    "adverseReactions": "clarinex tablets , reditabs , oral solution contraindicated patients hypersensitive medication ingredients loratadine [ ( 5.1 ) ( 6.2 ) ] .",
    "indications_original": "CLARINEX is a histamine-1 (H1) receptor antagonist indicated for: Seasonal Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 2 years of age and older. ( 1.1 ) Perennial Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 6 months of age and older. ( 1.2 ) Chronic Idiopathic Urticaria: symptomatic relief of pruritus, reduction in the number of hives, and size of hives in patients 6 months of age and older. ( 1.3 )",
    "contraindications_original": "Although the oral solution and the orally disintegrating tablet formulation of desloratadine may be available in the marketplace, CLARINEX® Oral Solution and CLARINEX® RediTabs® Tablets are no longer marketed.\n                  CLARINEX Tablets, Oral Solution, or RediTabs Tablets may be taken without regard to meals. Place CLARINEX (desloratadine) RediTabs Tablets on the tongue and allow to disintegrate before swallowing. Tablet disintegration occurs rapidly. Administer with or without water. Take tablet immediately after opening the blister.\n                  The age-appropriate dose of CLARINEX Oral Solution should be administered with a commercially available measuring dropper or syringe that is calibrated to deliver 2 mL and 2.5 mL (½ teaspoon).",
    "warningsAndPrecautions_original": "CLARINEX Tablets:\n                  \n                  \n                     Embossed “C5”, light blue, film-coated tablets that are packaged in high-density polyethylene plastic bottles of 100 (NDC 78206-119-01).\n                     Embossed with elongated letters “S” and “P”, light blue, film-coated tablets that are packaged in high-density polyethylene plastic bottles of 100 (NDC 78206-188-01).",
    "adverseReactions_original": "CLARINEX Tablets, RediTabs, and Oral Solution are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see Warnings and Precautions (5.1) and Adverse Reactions (6.2)]."
}